Echocardiography-based pressure–volume loop assessment in the evaluation for the effects of indoxyl sulfate on cardiovascular function

Authors:

Abstract
Indoxyl sulfate (IS), a uremic toxin, has been reported to have hypertrophic effects on the heart. Previous studies, however, have shown no association between elevated IS levels and cardiovascular outcomes in hemodialysis patients. We hypothesized that, despite left ventricular (LV) hypertrophy, myocardial contractility and ventricular–arterial coupling would remain preserved, and that this would explain the reason for the absence of prognostic impact of IS.
Funding Information
  • Kureha Corporation (N/A)

This publication has 34 references indexed in Scilit: